[Cidofovir for the treatment of recurrent respiratory papillomatosis]

Pichon Riviere A, Augustovski F, Garcia Marti S, Glujovsky D, Alcaraz A, Lopez A, Rey-Ares L, Bardach A, Ciapponi A, Gonzalez L
Record ID 32014000263
Authors' objectives: To assess the available evidence on the efficacy, safety and coverage related aspects regarding the use of cidofovir in patients with Recurrent Respiratory Papillomatosis.
Authors' recommendations: The use of cidofovir as adjuvant therapy in patients with RRP is based on low methodological quality evidence. The only RCT published did not show differences between the use of placebo and cidofovir.
Project Status: Completed
Year Published: 2013
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Argentina
MeSH Terms
  • Humans
  • Respiratory Tract Infections
  • Papillomavirus Infections
  • Cytosine
  • Organophosphonates
Organisation Name: Institute for Clinical Effectiveness and Health Policy
Contact Address: Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name: info@iecs.org.ar
Contact Email: info@iecs.org.ar
Copyright: Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.